Micro-scaled method holds promise as improved cancer diagnostic platform

A new-method analyzes the combination of tumor genetic material (genomics) with deep protein and phosphoprotein characterization (proteomics) using a single-needle core biopsy from a patient's tumor, providing more detailed information about the cancer than conventional approaches.

from Top Health News -- ScienceDaily https://ift.tt/36puXUA